Clinuvel Pharmaceuticals
CUV.AX
#7530
Rank
S$0.52 B
Marketcap
S$10.44
Share price
0.00%
Change (1 day)
10.25%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: S$42.76 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$62.5 Million. In 2025 the company made an earning of S$42.76 Million, an increase over its 2024 earnings that were of S$42.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025S$42.76 M0.26%
2024S$42.64 M11.35%
2023S$38.3 M28.31%
2022S$29.85 M22.8%
2021S$24.3 M112.63%
2020S$11.43 M-28.73%
2019S$16.04 M32.79%
2018S$12.08 M75.41%
2017S$6.88 M-332.52%
2016-S$2.97 Million-70.68%
2015-S$10.11 Million53.78%
2014-S$6.58 Million-16.1%
2013-S$7.84 Million-37.92%
2012-S$12.62 Million-18.19%
2011-S$15.42 Million25.31%
2010-S$12.31 Million-21.53%
2009-S$15.69 Million-11.27%
2008-S$17.68 Million80.4%
2007-S$9.8 Million-2.46%
2006-S$10.05 Million-5.35%
2005-S$10.62 Million60.55%
2004-S$6.61 Million97.37%
2003-S$3.35 Million50.62%
2002-S$2.23 Million121.22%
2001-S$1.01 Million254.48%
2000-S$0.29 Million